Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397

NCT01466244 · clinicaltrials.gov ↗

COMPLETED

Status

42

Enrollment

NETWORK

Sponsor class

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: cisplatin
GENETIC: gene expression analysis
GENETIC: microarray analysis
OTHER: immunohistochemistry staining method
OTHER: laboratory biomarker analysis

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]